Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-08

Clinical Trial Update: Ciprofloxacin for the Prevention of Meningococcal Meningitis [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating ciprofloxacin for prevention of meningococcal meningitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Epicentre | Conditions: Meningitis, Meningococcal | Phase 4 | Status: COMPLETED